Nicollet Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History

Nicollet Investment Management, Inc.

$271 Million
Q1 2024

A detailed history of Nicollet Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nicollet Investment Management, Inc. holds 20,521 shares of IONS stock, worth $935,757. This represents 0.33% of its overall portfolio holdings.

Number of Shares

20,521

Previous 9,776 109.91%

Holding current value

$935,757

Previous $495,000 79.8%

% of portfolio

0.33%

Previous 0.2%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$42.03 - $53.55 $451,612 - $575,394	10,745 Added 109.91%	20,521 $890,000
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $48,076 - $57,206	1,108 Added 12.78%	9,776 $495,000
Q3 2023 Nov 09, 2023	SELL	$38.5 - $47.13 $3,465 - $4,241	-90 Reduced 1.03%	8,668 $393,000
Q2 2023 Aug 08, 2023	BUY	$34.73 - $43.33 $10,175 - $12,695	293 Added 3.46%	8,758 $359,000
Q1 2023 May 09, 2023	BUY	$33.58 - $41.2 $17,696 - $21,712	527 Added 6.64%	8,465 $303,000

Q4 2022 Feb 06, 2023	SELL	$37.12 - $46.52 $21,158 - $26,516	-570 Reduced 6.7%	7,938 $300,000
Q3 2022 Nov 08, 2022	BUY	$36.54 - $48.66 $2,411 - $3,211	66 Added 0.78%	8,508 $376,000
Q2 2022 Aug 11, 2022	BUY	$31.71 - $43.0 $5,485 - $7,439	173 Added 2.09%	8,442 $313,000
Q1 2022 May 04, 2022	SELL	$29.88 - $37.04 $7,021 - $8,704	-235 Reduced 2.76%	8,269 $306,000
Q4 2021 Feb 09, 2022	SELL	$25.61 - $35.1 $51,143 - $70,094	-1,997 Reduced 19.02%	8,504 $259,000
Q3 2021 Nov 05, 2021	SELL	$33.54 - $40.55 $100 - $121	-3 Reduced 0.03%	10,501 $352,000
Q2 2021 Jul 28, 2021	SELL	$34.54 - $47.25 $10,603 - $14,505	-307 Reduced 2.84%	10,504 $419,000
Q1 2021 May 10, 2021	SELL	$42.51 - $63.78 $2,465 - $3,699	-58 Reduced 0.53%	10,811 $486,000
Q4 2020 Feb 09, 2021	BUY	$45.3 - $60.27 $23,012 - $30,617	508 Added 4.9%	10,869 $615,000
Q3 2020 Nov 10, 2020	SELL	$47.45 - $62.95 $1,376 - $1,825	-29 Reduced 0.28%	10,361 $492,000
Q2 2020 Aug 04, 2020	BUY	$46.85 - $61.05 $18,037 - $23,504	385 Added 3.85%	10,390 $613,000
Q1 2020 May 04, 2020	SELL	$41.6 - $63.4 $13,936 - $21,239	-335 Reduced 3.24%	10,005 $473,000
Q4 2019 Feb 07, 2020	SELL	$53.85 - $65.27 $15,616 - $18,928	-290 Reduced 2.73%	10,340 $625,000
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $4,429 - $5,411	75 Added 0.71%	10,630 $637,000
Q2 2019 Aug 09, 2019	SELL	$62.09 - $86.14 $4,346 - $6,029	-70 Reduced 0.66%	10,555 $678,000
Q1 2019 May 02, 2019	BUY	$52.92 - $81.17 $1,587 - $2,435	30 Added 0.28%	10,625 $862,000
Q4 2018 Feb 11, 2019	SELL	$43.37 - $59.54 $4,120 - $5,656	-95 Reduced 0.89%	10,595 $573,000
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $18,652 - $23,359	435 Added 4.24%	10,690 $551,000
Q2 2018 Aug 09, 2018	BUY	$40.53 - $50.7 $13,374 - $16,731	330 Added 3.32%	10,255 $427,000
Q1 2018 May 10, 2018	BUY	$44.08 - $55.05 $1,322 - $1,651	30 Added 0.3%	9,925 $437,000
Q4 2017 Feb 06, 2018	BUY	$50.3 - $64.39 $497,718 - $637,139	9,895	9,895 $498,000

Others Institutions Holding IONS

# of Institutions

397

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.47B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicollet Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicollet Investment Management, Inc. with notifications on news.

Account

Nicollet Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History